{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:26:33Z","timestamp":1792700793302,"version":"4.5.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mature dendritic cells (mDCs) can trigger the effector functions of natural killer (NK) cells. Knock-out, small-interfering RNA or neutralizing antibodies targeting interleukin 12 (IL-12) subunits revealed a critical role for IL-12 in NK cell interferon \u03b3 (IFN-\u03b3) secretion promoted by mDCs. However, NK cell activation by DCs also required direct cell-to-cell contacts. DC-mediated NK cell activation involved the formation of stimulatory synapses between DCs and NK cells. The formation of DC\/NK cell conjugates depended on cytoskeleton remodeling and lipid raft mobilization in DCs. Moreover, the disruption of the DC cytoskeleton using pharmacologic agents or the loss-of-function mutation of the Wiskott-Aldrich syndrome protein abolished the DC-mediated NK cell activation. Synapse formation promoted the polarized secretion of preassembled stores of IL-12 by DCs toward the NK cell. The synaptic delivery of IL-12 by DCs was required for IFN-\u03b3 secretion by NK cells, as assessed using inhibitors of cytoskeleton rearrangements and transwell experiments. Therefore, the cross-talk between DCs and NK cells is dictated by functional synapses. (Blood. 2004;104:3267-3275)<\/jats:p>","DOI":"10.1182\/blood-2004-01-0380","type":"journal-article","created":{"date-parts":[[2004,7,9]],"date-time":"2004-07-09T00:19:16Z","timestamp":1089332356000},"page":"3267-3275","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":282,"title":["NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs"],"prefix":"10.1182","volume":"104","author":[{"given":"Christophe","family":"Borg","sequence":"first","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelali","family":"Jalil","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Laderach","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Maruyama","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiro","family":"Wakasugi","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Charrier","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ryffel","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cambi","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Figdor","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Galy","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Caignard","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[{"name":"From the ERM0208 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Department of Clinical Biology, Institut Gustave Roussy, Villejuif, France; U487 INSERM, Institut Gustave Roussy, Villejuif, France; U362 INSERM, Institut Gustave Roussy, Villejuif Ge\u0301ne\u0301thon, Evry, France; Pharmacology Division, National Cancer Center, Tokyo, Japan; GEM2358, Centre National de la Recherche Scientifique (CNRS), Orleans, France; and University Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222472329300_REF1","doi-asserted-by":"crossref","unstructured":"Trinchieri G. Biology of NK cells. Adv Immunol. 1989;47: 187-376.","DOI":"10.1016\/S0065-2776(08)60664-1"},{"key":"2020021222472329300_REF2","doi-asserted-by":"crossref","unstructured":"Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001;1: 41-49.","DOI":"10.1038\/35095564"},{"key":"2020021222472329300_REF3","doi-asserted-by":"crossref","unstructured":"Biron CA, Byron KS, Sullivan JL. Severe herpes virus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320: 1731-1735.","DOI":"10.1056\/NEJM198906293202605"},{"key":"2020021222472329300_REF4","doi-asserted-by":"crossref","unstructured":"Brown MG, Dokun AO, Heusel JW, et al. Vital involvement of natural killer cell activation receptor in resistance to viral infection. Science. 2001;292: 934-937.","DOI":"10.1126\/science.1060042"},{"key":"2020021222472329300_REF5","doi-asserted-by":"crossref","unstructured":"Ljunggren HG, Ka\u0308rre K. Host resistance directed selectively against H-2-deficient lymphoma variants. J Exp Med. 1985;162: 1745-1759.","DOI":"10.1084\/jem.162.6.1745"},{"key":"2020021222472329300_REF6","doi-asserted-by":"crossref","unstructured":"Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human NK cell-mediated cytolysis. Annu Rev Immunol. 2001;19: 197-223.","DOI":"10.1146\/annurev.immunol.19.1.197"},{"key":"2020021222472329300_REF7","doi-asserted-by":"crossref","unstructured":"Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295: 2029-2031.","DOI":"10.1126\/science.1068440"},{"key":"2020021222472329300_REF8","doi-asserted-by":"crossref","unstructured":"Lou Z, Jeremovic D, Billadeau DD, et al. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med. 2000;191: 347-354.","DOI":"10.1084\/jem.191.2.347"},{"key":"2020021222472329300_REF9","doi-asserted-by":"crossref","unstructured":"Davis DM, Chiu I, Fassett M, et al. The human natural killer cell immune synapse. Proc Natl Acad Sci U S A. 1999;96: 15062-15067.","DOI":"10.1073\/pnas.96.26.15062"},{"key":"2020021222472329300_REF10","doi-asserted-by":"crossref","unstructured":"Ericksson M, Ryan JC, Nakamura MC, et al. Ly49A inhibitory receptors redistribute on natural killer cells during target cell interaction. Immunology. 1999;97: 341-347.","DOI":"10.1046\/j.1365-2567.1999.00800.x"},{"key":"2020021222472329300_REF11","doi-asserted-by":"crossref","unstructured":"Fassett MS, Davis DM, Valter MM, et al. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A. 2001;98: 14547-14552.","DOI":"10.1073\/pnas.211563598"},{"key":"2020021222472329300_REF12","doi-asserted-by":"crossref","unstructured":"Vyas YM, Mehta KM, Morgan M, et al. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol. 2001;167: 4358-4367.","DOI":"10.4049\/jimmunol.167.8.4358"},{"key":"2020021222472329300_REF13","doi-asserted-by":"crossref","unstructured":"McCann FE, Vanherberghen B, Eleme K, et al. The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses. J Immunol. 2003;15: 2862-2870.","DOI":"10.4049\/jimmunol.170.6.2862"},{"key":"2020021222472329300_REF14","doi-asserted-by":"crossref","unstructured":"Orange JS, Ramesh N, Remold-O'Donnell E, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002;99: 11351-11356.","DOI":"10.1073\/pnas.162376099"},{"key":"2020021222472329300_REF15","doi-asserted-by":"crossref","unstructured":"Orange JS, Harris KE, Andzelm MM, et al. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci U S A. 2003;100: 14151-14156.","DOI":"10.1073\/pnas.1835830100"},{"key":"2020021222472329300_REF16","doi-asserted-by":"crossref","unstructured":"Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: crosstalk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5: 405-411.","DOI":"10.1038\/7403"},{"key":"2020021222472329300_REF17","doi-asserted-by":"crossref","unstructured":"Gerosa F, Baldani-Guerra B, Nisii C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002;195: 327-333.","DOI":"10.1084\/jem.20010938"},{"key":"2020021222472329300_REF18","doi-asserted-by":"crossref","unstructured":"Piccioli D, Sbrana S, Melandri E, et al. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med. 2002;195: 335-341.","DOI":"10.1084\/jem.20010934"},{"key":"2020021222472329300_REF19","unstructured":"Fernandez NC, Flament C, Crepineau F, et al. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC\/NK cell cross talk. Eur Cytokine Netw. 2002;13: 17-27."},{"key":"2020021222472329300_REF20","doi-asserted-by":"crossref","unstructured":"Ferlazzo G, Tsang ML, Moretta L, et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195: 341-351.","DOI":"10.1084\/jem.20011149"},{"key":"2020021222472329300_REF21","doi-asserted-by":"crossref","unstructured":"Andrews DM, Scalzo AA, Yokoyama WM, et al. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol. 2003;4: 175-181.","DOI":"10.1038\/ni880"},{"key":"2020021222472329300_REF22","doi-asserted-by":"crossref","unstructured":"Moretta A. NK and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol. 2002;2: 957-964.","DOI":"10.1038\/nri956"},{"key":"2020021222472329300_REF23","doi-asserted-by":"crossref","unstructured":"Yu Y, Hagihara M, Ando K, et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol. 2001;166: 1590-1600.","DOI":"10.4049\/jimmunol.166.3.1590"},{"key":"2020021222472329300_REF24","doi-asserted-by":"crossref","unstructured":"Jinushi M, Takehara T, Kanto T, et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation impairment in chronic hepatitis C virus infection. J Immunol. 2003;170: 1249-1256.","DOI":"10.4049\/jimmunol.170.3.1249"},{"key":"2020021222472329300_REF25","doi-asserted-by":"crossref","unstructured":"Harborth JS, Elbashir M, Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci. 2001;114: 4557-4565.","DOI":"10.1242\/jcs.114.24.4557"},{"key":"2020021222472329300_REF26","doi-asserted-by":"crossref","unstructured":"Elbashir SM, Harborth JS, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002;26: 199-213.","DOI":"10.1016\/S1046-2023(02)00023-3"},{"key":"2020021222472329300_REF27","doi-asserted-by":"crossref","unstructured":"Laderach D, Compagno D, Danos O, et al. RNA interference shows critical requirement for NF-kappaB p50 in the production of IL-12 by human dendritic cells. J Immunol. 2003;171: 1750-1757.","DOI":"10.4049\/jimmunol.171.4.1750"},{"key":"2020021222472329300_REF28","doi-asserted-by":"crossref","unstructured":"Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 1998;14: 111-136.","DOI":"10.1146\/annurev.cellbio.14.1.111"},{"key":"2020021222472329300_REF29","doi-asserted-by":"crossref","unstructured":"Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997;387: 569-572.","DOI":"10.1038\/42408"},{"key":"2020021222472329300_REF30","doi-asserted-by":"crossref","unstructured":"Bromley SK, Burack WR, Johnson KG, et al. The immunological synapse. Ann Rev Immunol. 2001;19: 375-396.","DOI":"10.1146\/annurev.immunol.19.1.375"},{"key":"2020021222472329300_REF31","doi-asserted-by":"crossref","unstructured":"Al-Awan MM, Rowden G, Lee TDG. Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol. 2001;166: 338-345.","DOI":"10.4049\/jimmunol.166.1.338"},{"key":"2020021222472329300_REF32","doi-asserted-by":"crossref","unstructured":"Stossel TP. On the crawling of animal cells. Science. 1993;260: 1086-1088.","DOI":"10.1126\/science.8493552"},{"key":"2020021222472329300_REF33","doi-asserted-by":"crossref","unstructured":"Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9: 81-99.","DOI":"10.1016\/S1074-7613(00)80590-7"},{"key":"2020021222472329300_REF34","doi-asserted-by":"crossref","unstructured":"Blanchard N, Di Bartolo V, Hivroz C. In the immune synapse, ZAP-70 controls T cell proliferation and recruitment of signaling proteins but not formation of the synaptic pattern. Immunity. 2002;17: 389-399.","DOI":"10.1016\/S1074-7613(02)00421-1"},{"key":"2020021222472329300_REF35","doi-asserted-by":"crossref","unstructured":"Al-Alwan MM, Rowden G, Lee TD, et al. The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J Immunol. 2001;166: 1452-1456.","DOI":"10.4049\/jimmunol.166.3.1452"},{"key":"2020021222472329300_REF36","doi-asserted-by":"crossref","unstructured":"Grakoui A, Bromley SK, Sumen C, et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 1999;285: 221-227.","DOI":"10.1126\/science.285.5425.221"},{"key":"2020021222472329300_REF37","doi-asserted-by":"crossref","unstructured":"Montoya FC, Sancho D, Bonello G, et al. Role of ICAM-3 in the initial interaction of T lymphocytes and APCs. Nat Immunol. 2002;3: 159-168.","DOI":"10.1038\/ni753"},{"key":"2020021222472329300_REF38","doi-asserted-by":"crossref","unstructured":"Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989;170: 827-845.","DOI":"10.1084\/jem.170.3.827"},{"key":"2020021222472329300_REF39","doi-asserted-by":"crossref","unstructured":"Trinchieri G. Interleukin 12: a cytokine at the interface of inflammatory and immunity. Adv Immunol. 1998;78: 83-243.","DOI":"10.1016\/S0065-2776(08)60387-9"},{"key":"2020021222472329300_REF40","doi-asserted-by":"crossref","unstructured":"D'Andrea A, Rengaraju M, Valliante NM, et al. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J Exp Med. 1992;176: 1387-1398.","DOI":"10.1084\/jem.176.5.1387"},{"key":"2020021222472329300_REF41","doi-asserted-by":"crossref","unstructured":"Ma X, Chow JM, Gri G, et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996;183: 147-157.","DOI":"10.1084\/jem.183.1.147"},{"key":"2020021222472329300_REF42","doi-asserted-by":"crossref","unstructured":"Grohmann U, Belladonna ML, Bianchi R, et al. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity. 1998;9: 315-323.","DOI":"10.1016\/S1074-7613(00)80614-7"},{"key":"2020021222472329300_REF43","doi-asserted-by":"crossref","unstructured":"Quinones M, Ahuja SK, Melby PC, et al. Preformed membrane-associated stores of interleukin 12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J Exp Med. 2000;192: 507-515.","DOI":"10.1084\/jem.192.4.507"},{"key":"2020021222472329300_REF44","doi-asserted-by":"crossref","unstructured":"Bliss SK, Butcher BA, Denkers EY. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J Immunol. 2000;165: 4515-4521.","DOI":"10.4049\/jimmunol.165.8.4515"},{"key":"2020021222472329300_REF45","doi-asserted-by":"crossref","unstructured":"Buentke E, Heffler LC, Wilson JL, et al. NK and dendritic cell contact in lesional atopic dermatitis skin\u2014Malessezia influenced cell interaction. J Invest Dermatol. 2002;119: 850-857.","DOI":"10.1046\/j.1523-1747.2002.00132.x"},{"key":"2020021222472329300_REF46","doi-asserted-by":"crossref","unstructured":"Campbell JJ, Quin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001;166: 6477-6482.","DOI":"10.4049\/jimmunol.166.11.6477"},{"key":"2020021222472329300_REF47","doi-asserted-by":"crossref","unstructured":"Zitvogel L. Dendritic and natural killer cells cooperate in the control\/switch of innate immunity. J Exp Med. 2002;195: F9-F14.","DOI":"10.1084\/jem.20012040"},{"key":"2020021222472329300_REF48","doi-asserted-by":"crossref","unstructured":"Ferlazzo G, Mu\u0308nz C. NK cell compartments and their activation by dendritic cells. J Immunol. 2004;172: 1333-1339.","DOI":"10.4049\/jimmunol.172.3.1333"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3267\/1703657\/zh802204003267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3267\/1703657\/zh802204003267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:30:09Z","timestamp":1624505409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/10\/3267\/18783\/NK-cell-activation-by-dendritic-cells-DCs-requires"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-01-0380","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]}}}